| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.5 |